| Identification | Back Directory | [Name]
Methanesulfonamide, N-[[1-[6-(trifluoromethyl)-4-quinazolinyl]-3-piperidinyl]methyl]- | [CAS]
2322245-42-9 | [Synonyms]
SRI-37330
Methanesulfonamide, N-[[1-[6-(trifluoromethyl)-4-quinazolinyl]-3-piperidinyl]methyl]- | [Molecular Formula]
C16H19F3N4O2S | [MOL File]
2322245-42-9.mol | [Molecular Weight]
388.41 |
| Chemical Properties | Back Directory | [Boiling point ]
524.2±60.0 °C(Predicted) | [density ]
1.371±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, stored under nitrogen | [solubility ]
DMSO : 100 mg/mL (257.46 mM; Need ultrasonic) | [form ]
Solid | [pka]
11.14±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and action and blocking hepatic glucose output, reversing obesity- and STZ-induced diabetes and hepatic steatosis. |
|
| Company Name: |
xinguokeji
|
| Tel: |
13120711461 |
| Website: |
|
|